JMP Securities maintains Enanta stock with $21 target
JMP Securities reiterated a Market Outperform rating on Enanta Pharmaceuticals (NASDAQ:ENTA) shares with a consistent price target of $21.00. The firm's analysis highlighted the company's solid ...
Daily54 分钟
Sanofi secures approval in India for chronic graft-versus-host disease drug Rezurock
Sanofi Healthcare India Pvt. Limited has announced receipt of marketing authorization for Rezurock (Belumosudil Tablets) in ...